14911 | 14911 | Cont. of a Study to Evaluate Implanting Peripheral Nerve Grafts Into Subjects With Parkinson's Disease (PD) During DBS | Not yet recruiting | No Results Available | Parkinson's Disease | Procedure: Autologous Peripheral Nerve Graft | https://ClinicalTrials.gov/show/NCT02369003 |
14912 | 14912 | T790M Mutation Positive 2nd Line STandard of cAre Registry | Withdrawn | No Results Available | Non Small Cell Lung Cancer | | https://ClinicalTrials.gov/show/NCT02368990 |
14913 | 14913 | Third Eye Panoramic Device Feasibility Evaluation | Enrolling by invitation | No Results Available | Colorectal Neoplasms | Device: Third Eye Panoramic device | https://ClinicalTrials.gov/show/NCT02368977 |
14914 | 14914 | IVF Treatment in Women With Immature Oocytes in Previous Cycle | Recruiting | No Results Available | Infertility | Drug: GnRH agonist 0.2 mg + hCG 250 mcg|Drug: high dose hCG 500 mcg | https://ClinicalTrials.gov/show/NCT02368964 |
14915 | 14915 | Phase I, Dose-escalation Trial of BAY1187982 in Subjects With Advanced Solid Tumors Known to Express Fibroblast Growth Factor Receptor 2 (FGFR2) | Recruiting | No Results Available | Medical Oncology | Drug: BAY1187982 | https://ClinicalTrials.gov/show/NCT02368951 |
14916 | 14916 | Prognosis in the Elderly Chinese: the Northern Shanghai Study | Enrolling by invitation | No Results Available | Cardiovascular Risk Factor | | https://ClinicalTrials.gov/show/NCT02368938 |
14917 | 14917 | Clinical Trial to Evaluate Safety and Efficacy of Ultherapyâ„¢ System for Lifting Skin on the Neck | Active, not recruiting | No Results Available | Wrinkles | Device: Ultherapyâ„¢ System | https://ClinicalTrials.gov/show/NCT02368925 |
14918 | 14918 | A Study to Assess the Safety, Tolerability and Effects of Single and Multiple Ascending Doses of ASP1707 in Healthy Male and Pre-menopausal Female Subjects, Including a Comparison of the Effects Under Fasted and Fed Conditions in Healthy Young Male Subjec | Completed | No Results Available | Pharmacokinetics of ASP1707|Pharmacodynamics of ASP1707 | Drug: ASP1707 single dose of dose levels 1 -7|Drug: Placebo single dose of dose levels 1-7|Drug: ASP1707 single dose fasted|Drug: ASP1707 single dose fed|Drug: ASP1707 multiple dose of dose levels 1-4|Drug: Placebo multiple dose of dose levels 1-4|Drug: ASP1707 multiple dose of dose levels 1-2|Drug: Placebo multiple dose of dose levels 1-2|Drug: ASP1707 parallel multiple dose of dose levels 1-3|Drug: Placebo parallel multiple dose | https://ClinicalTrials.gov/show/NCT02368912 |
14919 | 14919 | Computerized Alcohol Misuse Intervention System for Health Care | Not yet recruiting | No Results Available | Alcoholism | Other: Computerized Alcohol Misuse Intervention | https://ClinicalTrials.gov/show/NCT02368899 |
14920 | 14920 | Lower or Standard Dose Regorafenib in Treating Patients With Refractory Metastatic Colorectal Cancer | Recruiting | No Results Available | Colon Adenocarcinoma|Fatigue|Palmar-Plantar Erythodysthesia|Rectal Adenocarcinoma|Recurrent Colon Carcinoma|Recurrent Rectal Carcinoma|Stage IVA Colon Cancer|Stage IVA Rectal Cancer|Stage IVB Colon Cancer|Stage IVB Rectal Cancer | Drug: Regorafenib|Drug: Clobetasol Propionate|Other: Pharmacological Study|Other: Quality-of-Life Assessment | https://ClinicalTrials.gov/show/NCT02368886 |
14921 | 14921 | the Use of a IPOM Mesh for Prevention of Parastomal Hernia | Completed | No Results Available | Parastomal Hernia | Procedure: Application of IPOM mesh | https://ClinicalTrials.gov/show/NCT02368873 |
14922 | 14922 | OXIRI [Oxaliplatin (O), Xeloda (X) and Irinotecan (I)] in Pancreatic Adenocarcinoma | Recruiting | No Results Available | Pancreatic Cancer | Drug: oxaliplatin, irinotecan, capecitabine | https://ClinicalTrials.gov/show/NCT02368860 |
14923 | 14923 | Urinary Tract Infections in Older Persons Admitted to a Psychogeriatric Ward | Not yet recruiting | No Results Available | Urinary Tract Infections | Device: Diagnostic tests|Device: Diagnostic tests | https://ClinicalTrials.gov/show/NCT02368847 |
14924 | 14924 | Psychoeducation for the Parents of Attention Deficit Hyperactivity Disorder (ADHD) Children | Completed | No Results Available | ADHD | Behavioral: psychoeducation | https://ClinicalTrials.gov/show/NCT02368834 |
14925 | 14925 | From Cytotrophoblast to Syncytiotrophoblast | Not yet recruiting | No Results Available | Syncytiotrophoblast | | https://ClinicalTrials.gov/show/NCT02368821 |
14926 | 14926 | Family Bereavement Initiative in the Free State, South Africa | Enrolling by invitation | No Results Available | Grief|Bereavement | Behavioral: Abangane Support Group | https://ClinicalTrials.gov/show/NCT02368808 |
14927 | 14927 | Non-inferiority of Pharmacological Prevention Alone Versus Pancreatic Stents to Prevent Post-ERCP Pancreatitis | Recruiting | No Results Available | Pancreatitis | Device: Pancreatic Stent|Drug: Indomethacin|Drug: Isosorbide Dinitrate|Drug: Ringer's lactate | https://ClinicalTrials.gov/show/NCT02368795 |
14928 | 14928 | Effects of Ketamine and Propofol in Otoacoustic Emissions (OAE) in Children | Completed | No Results Available | Normal Healthy Ears|Ketamine and Propofol Effects on Hemodynamics|Ketamine and Propofol Effects on TEOAE and DPOAE | | https://ClinicalTrials.gov/show/NCT02368782 |
14929 | 14929 | Assessment of Tele-expertise for Frozen Section Diagnosis | Recruiting | No Results Available | Frozen Sections | Device: During Tele-expertise | https://ClinicalTrials.gov/show/NCT02368769 |
14930 | 14930 | Long-Term Efficacy and Safety of Intravitreal Aflibercept Injections for the Treatment of Diabetic Macular Edema in Subjects Who Completed the Three Year VISTA-DME Trial (The Endurance 2 Trial) | Enrolling by invitation | No Results Available | Diabetic Macular Edema | Drug: Aflibercept | https://ClinicalTrials.gov/show/NCT02368756 |
14931 | 14931 | QUality of Life in pAtients With Mild to modeRate Active procTitis Treated by mesalaZine (Pentasa®) | Not yet recruiting | No Results Available | Active Ulcerative Proctitis | Drug: mesalazine | https://ClinicalTrials.gov/show/NCT02368743 |
14932 | 14932 | Documentation of the Efficacy of Desmopressin Within the Context of Surgical Procedures | Recruiting | No Results Available | Platelet Dysfunction | Drug: desmopressin | https://ClinicalTrials.gov/show/NCT02368730 |
14933 | 14933 | An Efficacy and Safety Study of PENTASA in Chinese Patients With Left-sided Active Ulcerative Colitis Followed by a 24-Week Open-Label Extension Phase | Recruiting | No Results Available | Ulcerative Colitis | Drug: Mesalazine Enema|Drug: Placebo Enema | https://ClinicalTrials.gov/show/NCT02368717 |
14934 | 14934 | Role of Endoplasmic Reticulum Stress in the Pathophysiology of Type 2 Diabetes | Recruiting | No Results Available | Diabetes Mellitus, Type 2|Endoplasmic Reticulum Stress | Other: No intervention | https://ClinicalTrials.gov/show/NCT02368704 |
14935 | 14935 | Efficacy and Safety of GTx-024 in Patients With Androgen Receptor-Positive Triple Negative Breast Cancer (AR+ TNBC) | Recruiting | No Results Available | Triple Negative Breast Cancer | Drug: GTx-024 | https://ClinicalTrials.gov/show/NCT02368691 |
14936 | 14936 | "Study of Halitosis in Patients With Advanced Chronic Periodontitis" | Completed | No Results Available | Periodontal Disease|Halitosis|Periodontitis | Procedure: Scaling and Root Planning (SRP)|Procedure: Full Mouth Scaling (FMS) | https://ClinicalTrials.gov/show/NCT02368678 |
14937 | 14937 | A Study to Evaluate the Efficacy and Safety of Amlodipine Besylate and Candesartan Cilexetil in Essential Hypertension Patient Who Are Not Adequately Controlled With Amlodipine Besylate Monotherapy | Recruiting | No Results Available | Essential Hypertension | Drug: Amlodipine 5mg|Drug: Amlodipine 5mg, Candesartan cilexetil 16mg|Drug: Amlodipine 10mg, Candesartan cilexetil 16mg | https://ClinicalTrials.gov/show/NCT02368665 |
14938 | 14938 | A Study to Evaluate the Efficacy and Safety of Amlodipine Besylate and Candesartan Cilexetil in Essential Hypertension Patient Who Are Not Adequately Controlled With Candesartan Cilexetil Monotherapy | Recruiting | No Results Available | Essential Hypertension | Drug: Candesartan cilexetil 16mg|Drug: Amlodipine 10mg, Candesartan cilexetil 16mg | https://ClinicalTrials.gov/show/NCT02368652 |
14939 | 14939 | Feasibility of a Modified Positive Airway Pressure Device to Treat Sleep Disordered Breathing | Recruiting | No Results Available | Sleep Apnea, Obstructive|Obesity Hypoventilation Syndrome | Device: F&P modified CPAP | https://ClinicalTrials.gov/show/NCT02368639 |
14940 | 14940 | Safety and Efficacy of the EndyMed Pro System Using RF Micro-needles Fractional Skin Remodeling | Not yet recruiting | No Results Available | Aging | Device: EndyMed Proâ„¢ RF Micro-Needles | https://ClinicalTrials.gov/show/NCT02368626 |